Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients
Public ClinicalTrials.gov record NCT00798369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Adaptive Dose-ranging, Multi-center, Single-blind, Double-dummy, Active-controlled Trial to Determine the Target Dose of Canakinumab (ACZ885) in the Treatment of Acute Flares in Gout Patients Who Are Refractory or Contraindicated to NSAIDs and/or Colchicine
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This 8-week study is designed to determine the target dose of canakinumab (ACZ885) for the management of acute flare in gout patients who are contraindicated to Non-Steroidal anti-inflammatory drugs and/or colchicine. The efficacy of ACZ885 will be compared to the corticosteroid triamcinolone acetonide.
Study identification
- NCT ID
- NCT00798369
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2008 (Type not available)
- Primary completion
- Aug 2009 (Actual)
- Completion
- Aug 2009 (Actual)
- Last update posted
- Apr 10, 2012
2008 – 2009
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group, LLC | Anniston | Alabama | 36207-5710 | — |
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Associated Pharmaceutical Research | Buena Park | California | 90620 | — |
| Northern California Institute for Bone Health | Oakland | California | 94609 | — |
| San Diego Arthritis & Osteoporosis Medical Clinic | San Diego | California | 92108 | — |
| Center for Clinical Trials of San Gabriel | West Covina | California | 91790 | — |
| Tampa Medical Group, P.A. | Tampa | Florida | 33614 | — |
| Florida Medical Clinic, PA | Zephyrhills | Florida | 33542 | — |
| Harbin Clinic | Rome | Georgia | 30165 | — |
| Intermountain Orthopedics | Boise | Idaho | 83702 | — |
| Northwest Clinical Trials | Boise | Idaho | 83704 | — |
| The Arthritis Center | Springfield | Illinois | 62704 | — |
| Cotton O'Neil Clinic | Topeka | Kansas | 66606 | — |
| Arthritis and Diabetes Clinic | Monroe | Louisiana | 71203 | — |
| Arthritis Consultants, Inc. | St Louis | Missouri | 63141 | — |
| Billings Clinic Research Center | Billings | Montana | 59101 | — |
| Montana Medical Research | Missoula | Montana | 59804 | — |
| Heartland Clinical Research, Inc. | Omaha | Nebraska | 68134 | — |
| New Mexico Clinical Research & Osteoporosis Center, Inc. | Albuquerque | New Mexico | 87106 | — |
| Regional Clinical Research Rheumatology Assoc. | Binghamton | New York | 13905 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Community Research Partners, Inc. | Varnville | South Carolina | 29944 | — |
| Comprehensive Rheumatology | Hendersonville | Tennessee | 37075 | — |
| MultiSpecialty Clinical Research | Johnson City | Tennessee | 37601 | — |
| Integrity Clinical Research, LLC | Milan | Tennessee | 38358 | — |
| Southwest Rheumatology | Mesquite | Texas | 75150 | — |
| Health Research of Hampton Roads | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00798369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 10, 2012 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00798369 live on ClinicalTrials.gov.